Search
4D Molecular Therapeutics Inc
FDMTAdd to Watchlist
9.660USD
+0.240+2.55%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
504.94MMarket Cap
LossP/E TTM
4D Molecular Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of 4D Molecular Therapeutics Inc is 6.61, ranking 314 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.76, which is -79.05% below the recent high of -0.79 and -270.06% above the recent low of -13.92.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
